ANVISA Compliance Checklist: Brazil Medical Cannabis 2026
Everything operators, manufacturers, patient associations, and investors need to know about Brazil’s 5 new ANVISA resolutions (RDC 1,011 to 1,015), regulatory deadlines, and seed-to-sale traceability requirements.
Get Your Free Checklist
Instant download — no commitment
We respect your privacy. Your information is used only to send the checklist and occasional product updates. Unsubscribe anytime.
What’s Inside the Checklist
Cultivation Checklist
All RDC 1,012 (research) and RDC 1,013 (medicinal) requirements — authorizations, GAP, GMP, traceability, and THC restrictions.
Manufacturing & Import
RDC 1,015 requirements: AFE, AE, CBPF, CGDP, SNGPC integration, Portuguese labeling, and child-resistant packaging.
Regulatory Sandbox
Complete RDC 1,014 guide for patient associations: eligibility, estimated costs, public call process, and operating rules.
Compliance Timeline
All critical dates: RDC 1,015 (May 2026), cultivation (August 2026), judicial transition (August 2027).
RDC 327 vs. 1,015 Comparison
Side-by-side table of all changes: administration routes, prescribers, compounding pharmacies, and more.
Priority Actions
Next-steps checklist with immediate and August 2026 actions — including booking your free GrowerIQ demo.
Seed-to-Sale Platform for ANVISA Compliance
GrowerIQ is a seed-to-sale traceability platform used by regulated cannabis operators across multiple jurisdictions. Our technology is built for complex regulatory environments — exactly like Brazil’s new multi-agency ANVISA framework.
- ✓ SNGPC integration for full traceability
- ✓ Digital batch records with electronic signatures (GMP)
- ✓ Automated multi-agency compliance reporting
- ✓ Cultivation analytics and environmental monitoring
- ✓ Portuguese-language support and documentation
See how GrowerIQ simplifies ANVISA compliance for your operation.